The Senate yesterday shelved a controversial amendment that could have impeded the enaction of the bill that includes the new version of MDUFMA, the Los Angeles Times reports. The amendment has nothing to do with devices -- it would have allowed drug reimportation, and its inclusion likely would have prompted President Bush to veto the whole thing. WhetherÂ drug reimportationÂ would have been a good or bad thing is not our concern here. What's important is that the move by the Senate means there is one less obstacle toward MDUFMA II becoming a reality.
MD+DI Online is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.